Based on preliminary unaudited financial information, the company expects total revenue, which includes license and royalty revenue from partners, to be approximately $30M for the fourth quarter 2024 and approximately $145M for the full year 2024, and U.S. XPOVIO net product revenue to be approximately $29M for the fourth quarter 2024 and approximately $113M for the full year 2024. FY24 revenue consensus $152.89M.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KPTI: